A Real-World Prognosis in Idiopathic Pulmonary Fibrosis: A Special Reference to the Role of Antifibrotic Agents for the Elderly.

Kojiro Honda,Takeshi Saraya,Haruyuki Ishii

Journal of clinical medicine（2023）

引用 0|浏览1

暂无评分

摘要

Even in elderly patients (≥75 years of age), antifibrotic agents demonstrated positive effects on survival probability and the frequency of acute exacerbation. These positive effects would be improved for earlier JRS/GAP stages or long-term use.

查看译文

关键词

idiopathic pulmonary fibrosis,pulmonary fibrosis,antifibrotic agents,elderly,real-world

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要